130
Participants
Start Date
November 30, 2003
Study Completion Date
August 31, 2006
Amifostine
Beth Israel Hospital, New York
Long Island Jewish Medical Center, New Hyde Park
Upstate NY Cancer R&E Foundation, Rochester
Cancer Center of Upper Delaware Valley, Milford
Montgomery Cancer Center, Norristown
Center for Cancer & Blood Disorders, Bethesda
Chesapeake Oncology-Hematology Associates, Glen Burnie
St. Agnes Health Care, Baltimore
The Center for Radiation Oncology, Danville
New Hanover Radiation, Wilmington
Charleston Cancer Center, Charleston
Ormand Memorial Cancer Center, Ormand Beach
University Community Hospital-Center for Cancer Care, Tampa
Sarasota Memorial Hospital, Sarasota
Florida Wellcare Alliance, Inverness
Florida Community Cancer Center, New Port Richey
St. John's Medical Research, Springfield
Cedars Sanai, Los Angeles
Radiation Oncology Center, Sacramento
Valley Medical Center, Renton
Providence Everett Medical Center, Everett
The Center for Cancer Care, Torrington
University of Kentucky, Lexington
Cooper University Hospital, Camden
Lead Sponsor
MedImmune LLC
INDUSTRY